title: Treatment of chronic type D hepatitis and concomitant human immunodeficiency infection with alpha-interferon.
authors.forename: M
authors.initials: M
authors.lastname: Buti
authors.forename: R
authors.initials: R
authors.lastname: Esteban
authors.forename: R
authors.initials: R
authors.lastname: Jardi
authors.forename: F
authors.initials: F
authors.lastname: Rodriguez-Frias
authors.forename: H
authors.initials: H
authors.lastname: Allende
authors.forename: M
authors.initials: M
authors.lastname: Cotrina
authors.forename: J
authors.initials: J
authors.lastname: Guardia
mesh_terms: D000328:Adult; D016516:CD4-CD8 Ratio; D005260:Female; D015483:HIV Antibodies / Q000032:analysis; D015658:HIV Infections / Q000150:complications / Q000276:immunology / Q000628:therapy*; D006679:HIV Seropositivity; D003699:Hepatitis D / Q000150:complications / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D008111:Liver Function Tests; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D011994:Recombinant Proteins
chemical_list: D015483:HIV Antibodies; D007370:Interferon Type I; D011994:Recombinant Proteins